Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 85

Sort by

Sort Order Select

Journal Articles

Hydroxyurea Use and Outcomes of Pregnancy in Sickle Cell Disease

Victor R. Gordeuk, MD, Barbara Kroner, PhD, Norma Pugh, PhD, Jane S. Hankins, MD MS, Abdullah Kutlar, MD, Allison A. King, MDMPH,PhD, Nirmish Shah, MD, Julie Kanter, MD, Jeffrey Glassberg, MD, Marsha Treadwell, PhD

Blood (2020) 136 (Supplement 1): 33.

https://doi.org/10.1182/blood-2020-143315

Published: 2020

Journal Articles

ETA Receptor Blockade and Vascular Function in Patients with Sickle Cell Disease

Daniel Adamkiewicz, Hongyan Xu, PhD, Latanya Bowman, RN, Leigh Wells, MSN, Niren Patel, MBBS, Ryan Harris, PhD CEP, FACSM, Jennifer Pollock, PhD, David M. Pollock, PhD, Steffen E. Meiler, MD, Abdullah Kutlar, MD

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-142477

Published: 2020

Journal Articles

Crizanlizumab Treatment Is Associated with Clinically Significant Reductions in Hospitalization in Patients with Sickle Cell Disease: Results from the Sustain Study

Kenneth I. Ataga, MD, Abdullah Kutlar, MD, Laurie DeBonnett, MD, Jeremie Lincy, Julie Kanter, MD

Blood (2019) 134 (Supplement_1): 2289.

https://doi.org/10.1182/blood-2019-125868

Published: 2019

Journal Articles

Downregulation of Cytoskeletal Protein Kazrin in Lung Endothelial Cells of Preclinical Sickle Cell Disease Mouse Model - Essential Role of Endothelial Barrier Function

Umapathy N Siddaramappa, PhD, Niren Patel, MBBS, Betty S. Pace, MD, Abdullah Kutlar, MD

Blood (2019) 134 (Supplement_1): 2258.

https://doi.org/10.1182/blood-2019-130924

Published: 2019

Journal Articles

Phase-I Study of ETA Receptor Antagonist Ambrisentan in Sickle Cell Disease

Abdullah Kutlar, MD, Jennifer Pollock, PhD, Steffen E. Meiler, MD, Ryan Harris, PhD CEP, FACSM, Xu Hongyan, PhD, Leigh Wells, MSN, Latanya Bowman, RN, Sharon Jones, BS, David M. Pollock, PhD

Blood (2019) 134 (Supplement_1): 617.

https://doi.org/10.1182/blood-2019-130036

Published: 2019

Journal Articles

Crizanlizumab 5.0 Mg/Kg Exhibits a Favorable Safety Profile in Patients with Sickle Cell Disease: Pooled Data from Two Phase II Studies

Julie Kanter, MD, Darla K Liles, MD, Kim Smith-Whitley, MD, Clark Brown, MD PhD, Abdullah Kutlar, MD, Brian Elliott, Amit Shah, Jeremie Lincy, Susan Poggio, Kenneth I. Ataga, MBBS

Blood (2019) 134 (Supplement_1): 991.

https://doi.org/10.1182/blood-2019-123965

Published: 2019

Journal Articles

A Multicenter Retrospective Noninterventional Follow-up Study in Patients with Sickle Cell Pain Crisis Who Previously Participated in the Sustain Trial in the United States Successor Study

Nirmish Shah, Ralph Boccia, Walter K. Kraft, Brandon M. Hardesty, Jincy Paulose, Dram Laine, Das Purkayastha, Savita Nandal, Abdullah Kutlar, MD

Blood (2018) 132 (Supplement 1): 4910.

https://doi.org/10.1182/blood-2018-99-111332

Published: 2018

Journal Articles

Established Prevention of Vaso-Occlusive Crises with Crizanlizumab Is Further Improved in Patients Who Follow the Standard Treatment Regimen: Post-Hoc Analysis of the Phase II Sustain Study

Darla K Liles, MD, Rodolfo Cançado, Julie Kanter, MD, Abdullah Kutlar, MD, Andreas Bruederle, Michael Shi, MD PhD, Federico Campigotto, Kenneth I. Ataga

Blood (2018) 132 (Supplement 1): 1082.

https://doi.org/10.1182/blood-2018-99-112201

Published: 2018

Journal Articles

Correlation of Serum Ferritin Levels with Liver Iron Concentration By MRI Measurement in Sickle Cell Patients with Transfusional Iron Overload

Germame Ajebo, MD, Abhishek A. Mangaonkar, MD, Imran Ahmad, MD MPH, Nadine Barrett, MSN, Leigh Wells, MSN, Niren Patel, MBBS, Hongyan Xu, PhD, Abdullah Kutlar, MD

Blood (2018) 132 (Supplement 1): 4926.

https://doi.org/10.1182/blood-2018-99-119597

Published: 2018

Journal Articles

Characteristics and Potential Biomarkers of Adult Sickle Cell Patients with Chronic Pain

Camila Albo, Sanjiv Kumar, PhD, Michael Pope, Bachelors/MDcal Student, Kyle Michael Kidwell, Bachelors/MDcal Student, Niren Patel, MBBS, Leigh Wells, MSN, Latanya Bowman, RN, Nadine Barrett, MSN, Xu Hongyan, PhD, Abdullah Kutlar, MD

Blood (2018) 132 (Supplement 1): 857.

https://doi.org/10.1182/blood-2018-99-115084

Published: 2018

Journal Articles

Erythroferrone (ERFE) and Hepcidin Levels in Sickle Cell Disease with and without Transfusional Iron Overload

Fahim Thawer, Abdullah Kutlar, MD, Latanya Bowman, RN, Leigh Wells, MSN, Xu Hongyan, PhD, Niren Patel, MBBS, Pritam Bora, BA

Blood (2017) 130 (Supplement 1): 3518.

https://doi.org/10.1182/blood.V130.Suppl_1.3518.3518

Published: 2017

Journal Articles

Crizanlizumab 5.0 Mg/Kg Increased the Time to First on-Treatment Sickle Cell Pain Crisis: A Subgroup Analysis of the Phase II Sustain Study

Julie Kanter, MD, Abdullah Kutlar, MD, Darla Liles, Rodolfo Cançado, Andreas Bruederle, Michael Shi, MD PhD, Zewen Zhu, Kenneth I Ataga, MD

Blood (2017) 130 (Supplement 1): 613.

https://doi.org/10.1182/blood.V130.Suppl_1.613.613

Published: 2017

Journal Articles

Vitamin D Repletion Mitigates Oxidative Stress Induced Pulmonary Artery Remodeling in Sickle Cell Disease

Julia Brittain, PhD, E. Leila Jerome Clay, MD, Ryan Harris, PhD CEP, FACSM, Itia Lee, BS, Abdullah Kutlar, MD, Sanjiv Kumar, PhD

Blood (2017) 130 (Supplement 1): 443.

https://doi.org/10.1182/blood.V130.Suppl_1.443.443

Published: 2017

Journal Articles

SUSTAIN: A Multicenter, Randomized, Placebo-Controlled, Double-Blind, 12-Month Study to Assess Safety and Efficacy of SelG1 with or without Hydroxyurea Therapy in Sickle Cell Disease Patients with Sickle Cell-Related Pain Crises

Kenneth I. Ataga, MD, Abdullah Kutlar, MD, Julie Kanter, MD, Darla Liles, MD, Rodolfo Cancado, MD, PhD, João Friedrisch, MD PhD, Troy H. Guthrie, MD, Jennifer Knight-Madden, MBBS, PhD, Ofelia A. Alvarez, MD, Victor R. Gordeuk, MD, Sandra Gualandro, MD PhD, Marina Pereira Collela, MD PhD, Wally R. Smith, MD, Scott A. Rollins, PhD, Jonathan W. Stocker, PhD, Russell P. Rother, PhD

Blood (2016) 128 (22): 1.

https://doi.org/10.1182/blood.V128.22.1.1

Published: 2016

Journal Articles

Evolution of Chronic Pain in Sickle Cell Disease

Michael Pope, BA, Camila Albo, Kyle Michael Kidwell, BS, Hongyan Xu, PhD, Latanya Bowman, BSN, Leigh Wells, MSN, Nadine Barrett, MSN, Sabine Fields, BSN, Pritam Bora, BA, E. Leila Jerome Clay, MD, Niren Patel, MBBS, Abdullah Kutlar, MD

Blood (2016) 128 (22): 1297.

https://doi.org/10.1182/blood.V128.22.1297.1297

Published: 2016

Journal Articles

Characteristics of Sickle Cell Patients with Frequent ED Visits and Hospitalizations: Demographic, Clinical, Laboratory and Psycho-Social Aspects

Kyle Michael Kidwell, BS, Camila Albo, Michael Pope, BA, Latanya Bowman, BSN, Hongyan Xu, PhD, Leigh Wells, MSN, Nadine Barrett, MSN, Sabine Fields, BSN, Pritam Bora, BA, Niren Patel, MBBS, Amy Allison, PhD, Abdullah Kutlar, MD

Blood (2016) 128 (22): 2501.

https://doi.org/10.1182/blood.V128.22.2501.2501

Published: 2016

Journal Articles

Demographic Features of a Mixed Urban/Rural Adult Sickle Cell Population:Opportunities and Challenges for Improving Health Care

Amauri Bowman, Sydney Taylor, Pritam Bora, Hongyan Xu, PhD, Leigh Wells, MS, Latanya Bowman, BS, Nadine Barrett, MS, Richard Lottenberg, MD, E. Leila Jerome Clay, MD, Betty Pace, MD, Matthew Lyon, MD, Robert Gibson, PhD, Abdullah Kutlar, MD

Blood (2015) 126 (23): 5594.

https://doi.org/10.1182/blood.V126.23.5594.5594

Published: 2015

Journal Articles

Emergency Department Physicians Management Versus Hospitalists Service Management Admittance Rates for Sickle Cell Disease Patients from an Emergency Department Observation Unit

Taylor Mueller, BS, LaShon Sturgis, MD PhD, Patrick Loeffler, BS, Ann-Marie Kuckinski, PhD, Abdullah Kutlar, MD, Robert Gibson, PhD, Matthew Lyon, MD

Blood (2015) 126 (23): 5568.

https://doi.org/10.1182/blood.V126.23.5568.5568

Published: 2015

Journal Articles

Frequency of Emergency Department Visits for Sickle Cell Disease Vaso-Occlusive Crisis and Its Contribution to Hospital Admission Rates

Patrick Loeffler, BS, Taylor Mueller, BS, Abdullah Kutlar, MD, Robert Gibson, PhD, LaShon Sturgis, MD PhD, Matthew Lyon, MD

Blood (2015) 126 (23): 5569.

https://doi.org/10.1182/blood.V126.23.5569.5569

Published: 2015

Journal Articles

Sickle Cell Disease: Challenges and Comfort in Providing Care By Family Physicians

Onameyore Utuama, MDMPH, Kitty Carter-Wicker, MD, Jennifer Herbert, MD, Robert Gibson, PhD, Abdullah Kutlar, MD, Ayaba Logan, Mbuyi Madeleine Kabongo, Tom Adamkiewicz, MD MSCR, FRCP(C)

Blood (2015) 126 (23): 5570.

https://doi.org/10.1182/blood.V126.23.5570.5570

Published: 2015

NARROW

Hydroxyurea Use and Outcomes of Pregnancy in Sickle Cell Disease

ETA Receptor Blockade and Vascular Function in Patients with Sickle Cell Disease

Crizanlizumab Treatment Is Associated with Clinically Significant Reductions in Hospitalization in Patients with Sickle Cell Disease: Results from the Sustain Study

Downregulation of Cytoskeletal Protein Kazrin in Lung Endothelial Cells of Preclinical Sickle Cell Disease Mouse Model - Essential Role of Endothelial Barrier Function

Phase-I Study of ETA Receptor Antagonist Ambrisentan in Sickle Cell Disease

Crizanlizumab 5.0 Mg/Kg Exhibits a Favorable Safety Profile in Patients with Sickle Cell Disease: Pooled Data from Two Phase II Studies

A Multicenter Retrospective Noninterventional Follow-up Study in Patients with Sickle Cell Pain Crisis Who Previously Participated in the Sustain Trial in the United States Successor Study

Established Prevention of Vaso-Occlusive Crises with Crizanlizumab Is Further Improved in Patients Who Follow the Standard Treatment Regimen: Post-Hoc Analysis of the Phase II Sustain Study

Correlation of Serum Ferritin Levels with Liver Iron Concentration By MRI Measurement in Sickle Cell Patients with Transfusional Iron Overload

Characteristics and Potential Biomarkers of Adult Sickle Cell Patients with Chronic Pain

Erythroferrone (ERFE) and Hepcidin Levels in Sickle Cell Disease with and without Transfusional Iron Overload

Crizanlizumab 5.0 Mg/Kg Increased the Time to First on-Treatment Sickle Cell Pain Crisis: A Subgroup Analysis of the Phase II Sustain Study

Vitamin D Repletion Mitigates Oxidative Stress Induced Pulmonary Artery Remodeling in Sickle Cell Disease

SUSTAIN: A Multicenter, Randomized, Placebo-Controlled, Double-Blind, 12-Month Study to Assess Safety and Efficacy of SelG1 with or without Hydroxyurea Therapy in Sickle Cell Disease Patients with Sickle Cell-Related Pain Crises

Evolution of Chronic Pain in Sickle Cell Disease

Characteristics of Sickle Cell Patients with Frequent ED Visits and Hospitalizations: Demographic, Clinical, Laboratory and Psycho-Social Aspects

Demographic Features of a Mixed Urban/Rural Adult Sickle Cell Population:Opportunities and Challenges for Improving Health Care

Emergency Department Physicians Management Versus Hospitalists Service Management Admittance Rates for Sickle Cell Disease Patients from an Emergency Department Observation Unit

Frequency of Emergency Department Visits for Sickle Cell Disease Vaso-Occlusive Crisis and Its Contribution to Hospital Admission Rates

Sickle Cell Disease: Challenges and Comfort in Providing Care By Family Physicians

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only